Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04866940

Validation and Implementation of 3T MRI Research Protocols

The Philips 3T imager installed on the Pavillon Baudot site is an imager dedicated solely to research. It is not located in hospital premises but in INSERM premises for which an authorization for biomedical research has been granted. This equipment is part of the Technical Platform of the UMR 1214 ToNIC whose main objective is the study of the human brain and the main pathologies that affect it.

MRI is an evolving technique, which is used in many research projects. Our technical platform must follow these developments and remain at the cutting edge. One of the essential services of our technical platform is to help set up research protocols and validate acquisition sequences. This development activity is therefore located upstream of research projects involving clinical or fundamental applications. The fact that we can provide our users with a regulatory framework to carry out these development tests for their Research Involving Human Subjects project is a necessity for our research support activity.

This study aims to provide a generic framework to test the feasibility of MRI sequences requested within the framework of protocols, but also to optimize MRI acquisition sequences already in place, to improve image quality and reduce artifacts that can degrade the quality of the images obtained.

In France, there are just over 35 centers with MRI dedicated to research and therefore with a validation protocol allowing them to validate their sequences.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UMR 1214 ToNIC INSERM

Toulouse, 31000, France

Location status: Recruiting

Location contact

PAYOUX Pierre

CONTACT

[email protected]

About this study

This is a prospective monocentric research on major participants (healthy and patients). The optimization of the sequences will be carried out in an incremental way from one control to the other: for each control, several sequences will be carried out for an acquisition time not exceeding one hour of cumulated acquisition (i.e. one hour and a half including the installation and the delays between the sequences). Each sequence lasts between 5 and 20 minutes.

At the end of the examination, the images obtained will be evaluated jointly by an expert neuroradiologist and a research engineer specialized in image analysis according to the criteria mentioned above. This analysis will make it possible to determine the parameters to be modified to improve image quality and to define the acquisition parameters for the next test.

As soon as a sequence is considered optimal, it will be tested on a small number of healthy controls (≈ 5) to ensure interindividual reproducibility of image quality parameters, and then if necessary in the presence of pathology in a few patients (≈ 5).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female, 18 years of age or older
  • Ability to cooperate and remain motionless for up to 1 hour (and lying down for 1.5 hours)
  • Ability to understand the instructions given
  • Subject who has given written and informed consent prior to any examination required by the research)
  • Subject affiliated to a social security system or benefiting from an equivalent system

Exclusion criteria

  • Persons deprived of liberty by judicial or administrative decision
  • Psychiatric disorders, disorders of cognitive functions, not allowing the realization of the MRI
  • Protected adults (subject to a measure of legal protection) or unable to express their consent
  • Subject with Contraindications to MRI

Treatment and study plan

Sequences test

Other

the realization of preliminary acquisitions to validate the feasibility of clinical or cognitive research protocols

Primary outcomes

  1. in general

    Time frame: at the end of studies ((i.e. one hour and a half including the installation and the delays between the sequences). Each sequence lasts between 5 and 20 minutes.

    optimization of parameters acquisition in order to suppress artefact

Study contacts

Contact information is provided by the study sponsor or research team.

DAGNAC, PHD

CONTACT

[email protected]

+33562746122

Nathalie VAYSSIERE, PHD

CONTACT

[email protected]

+33562746132

Sponsors and collaborators

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Other Gov

Registry information

Acronym: VALIDIRM

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Apr 30, 2021
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.